Delta sleep-inducing peptide, usually abbreviated DSIP, is a nine-amino-acid sequence (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) first described in the 1970s during electrophysiological experiments in rabbits. Its name records the observation that prompted its isolation rather than an established mechanism, and decades later its biology remains one of the more open questions in peptide research.

Structure and Origin

DSIP is small, linear, and unmodified: no cyclization, no D-amino acid substitutions, and no terminal capping. That makes it structurally straightforward but also unremarkable in terms of stability engineering, since none of the usual protective modifications are present. The sequence is highly conserved across species and has been reported in a variety of tissues rather than being confined to the brain, a distribution pattern that has itself become a subject of study. At roughly 850 daltons it sits well within the range where standard reverse-phase HPLC and mass spectrometry give clean identity and purity data, so certificate review is comparatively simple and the expected mass is easy to verify against the sequence.

What Research Has Examined

The original studies were electrophysiological, and subsequent laboratory work has ranged more widely: binding and distribution studies, stress-response endpoints in animal models, and repeated attempts to identify a specific receptor. That last point is the crux of the ongoing uncertainty, since no single high-affinity receptor has been firmly established, which complicates mechanistic interpretation of any observed effect. Research suggests that some reported activity may be indirect, and reviews of the literature routinely note inconsistent replication across models and species. For anyone designing a study, this makes well-specified controls and clearly defined endpoints unusually important, and it argues for treating older published findings as hypotheses to test rather than as settled background.

Stability and Handling in the Laboratory

As an unprotected linear peptide with an aspartate residue and free termini, DSIP is a plausible candidate for degradation pathways such as deamidation and enzymatic cleavage, so solution stability should not be assumed. Lyophilized material stored cold and dry is the standard baseline; solutions are typically treated as short-lived, and freeze-thaw cycles are limited. Documenting the age of a working solution alongside results helps separate true experimental variability from simple degradation. Researchers assembling a comparison set of neuro-focused sequences can browse the product catalogue.

Research use only. This content is for informational and research purposes, is not medical advice, and these compounds are not for human or veterinary use.